HEADER HYDROLASE, BLOOD CLOTTING 25-SEP-08 3ENS TITLE CRYSTAL STRUCTURE OF HUMAN FXA IN COMPLEX WITH METHYL (2Z)-3-[(3- TITLE 2 CHLORO-1H-INDOL-7-YL)AMINO]-2-CYANO-3-{[(3S)-2-OXO-1-(2-OXO-2- TITLE 3 PYRROLIDIN-1-YLETHYL)AZEPAN-3-YL]AMINO}ACRYLATE COMPND MOL_ID: 1; COMPND 2 MOLECULE: FACTOR X LIGHT CHAIN; COMPND 3 CHAIN: A, C; COMPND 4 FRAGMENT: SEQUENCE DATABASE RESIDUES 93-178; COMPND 5 EC: 3.4.21.6; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: ACTIVATED FACTOR XA HEAVY CHAIN; COMPND 8 CHAIN: B, D; COMPND 9 FRAGMENT: SEQUENCE DATABASE RESIDUES 235-472; COMPND 10 EC: 3.4.21.6 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 OTHER_DETAILS: BLOOD; SOURCE 6 MOL_ID: 2; SOURCE 7 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 8 ORGANISM_COMMON: HUMAN; SOURCE 9 ORGANISM_TAXID: 9606; SOURCE 10 OTHER_DETAILS: BLOOD KEYWDS SERINE PROTEASE, HYDROLASE, EPIDERMAL GROWTH FACTOR LIKE DOMAIN, KEYWDS 2 BLOOD COAGULATION FACTOR, CLEAVAGE ON PAIR OF BASIC RESIDUES, EGF- KEYWDS 3 LIKE DOMAIN, GAMMA-CARBOXYGLUTAMIC ACID, GLYCOPROTEIN, KEYWDS 4 HYDROXYLATION, ZYMOGEN, BLOOD CLOTTING EXPDTA X-RAY DIFFRACTION AUTHOR H.E.KLEI REVDAT 3 25-OCT-17 3ENS 1 REMARK REVDAT 2 13-JUL-11 3ENS 1 VERSN REVDAT 1 30-DEC-08 3ENS 0 JRNL AUTH Y.SHI,D.SITKOFF,J.ZHANG,H.E.KLEI,K.KISH,E.C.LIU,K.S.HARTL, JRNL AUTH 2 S.M.SEILER,M.CHANG,C.HUANG,S.YOUSSEF,T.E.STEINBACHER, JRNL AUTH 3 W.A.SCHUMACHER,N.GRAZIER,A.PUDZIANOWSKI,A.APEDO,L.DISCENZA, JRNL AUTH 4 J.YANCHUNAS,P.D.STEIN,K.S.ATWAL JRNL TITL DESIGN, STRUCTURE-ACTIVITY RELATIONSHIPS, X-RAY CRYSTAL JRNL TITL 2 STRUCTURE, AND ENERGETIC CONTRIBUTIONS OF A CRITICAL P1 JRNL TITL 3 PHARMACOPHORE: 3-CHLOROINDOLE-7-YL-BASED FACTOR XA JRNL TITL 4 INHIBITORS. JRNL REF J.MED.CHEM. V. 51 7541 2008 JRNL REFN ISSN 0022-2623 JRNL PMID 18998662 JRNL DOI 10.1021/JM800855X REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.03 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.480 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.3 REMARK 3 NUMBER OF REFLECTIONS : 30221 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.225 REMARK 3 R VALUE (WORKING SET) : 0.223 REMARK 3 FREE R VALUE : 0.286 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.310 REMARK 3 FREE R VALUE TEST SET COUNT : 1000 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 19.0292 - 4.3843 0.99 4331 148 0.2072 0.2468 REMARK 3 2 4.3843 - 3.4869 0.99 4237 146 0.1892 0.2488 REMARK 3 3 3.4869 - 3.0482 0.98 4217 144 0.2159 0.2739 REMARK 3 4 3.0482 - 2.7704 0.97 4170 142 0.2426 0.3393 REMARK 3 5 2.7704 - 2.5724 0.97 4128 142 0.2420 0.3087 REMARK 3 6 2.5724 - 2.4210 0.96 4101 140 0.2533 0.3254 REMARK 3 7 2.4210 - 2.3000 0.95 4037 138 0.2550 0.3573 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : 0.40 REMARK 3 B_SOL : 46.43 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.430 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 28.560 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 29.92 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 5.95910 REMARK 3 B22 (A**2) : -5.07220 REMARK 3 B33 (A**2) : -0.88690 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.72480 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.005 5237 REMARK 3 ANGLE : 0.946 7018 REMARK 3 CHIRALITY : 0.064 740 REMARK 3 PLANARITY : 0.004 907 REMARK 3 DIHEDRAL : 18.112 1938 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3ENS COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 26-SEP-08. REMARK 100 THE DEPOSITION ID IS D_1000049551. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-DEC-99 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.50 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : OSMIC REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV++ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 30240 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.3 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.10000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.38 REMARK 200 COMPLETENESS FOR SHELL (%) : 94.5 REMARK 200 DATA REDUNDANCY IN SHELL : 2.40 REMARK 200 R MERGE FOR SHELL (I) : 0.35100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.66 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.44 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 15-22% W/V PEG MME 5000, 0.01 M REMARK 280 CALCIUM ACETATE, 0.35 M SODIUM ACETATE, 0.1 M LITHIUM SULFATE, REMARK 280 0.1 M MES, PH 6.500000, VAPOR DIFFUSION HANGING DROP, REMARK 280 TEMPERATURE 298K, VAPOR DIFFUSION, HANGING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 39.43050 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2930 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16470 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -33.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2990 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16050 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -32.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 85 REMARK 465 ASP A 86 REMARK 465 GLY A 87 REMARK 465 ASP A 88 REMARK 465 GLN A 89 REMARK 465 GLU A 91 REMARK 465 THR A 92 REMARK 465 GLY A 104 REMARK 465 LEU A 105 REMARK 465 GLY A 106 REMARK 465 LYS C 85 REMARK 465 ASP C 86 REMARK 465 GLY C 87 REMARK 465 ASP C 88 REMARK 465 THR C 92 REMARK 465 SER C 93 REMARK 465 GLY C 104 REMARK 465 LEU C 105 REMARK 465 GLY C 106 REMARK 465 GLU C 107 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 CYS A 90 O REMARK 470 LYS A 100 CG CD CE NZ REMARK 470 LYS A 102 CD CE NZ REMARK 470 GLN B 75 CG CD OE1 NE2 REMARK 470 GLN C 89 N CB CG CD OE1 NE2 REMARK 470 GLU C 91 CA C O CB CG CD OE1 REMARK 470 GLU C 91 OE2 REMARK 470 LYS C 100 CG CD CE NZ REMARK 470 LYS C 102 CG CD CE NZ REMARK 470 GLN C 144 CG CD OE1 NE2 REMARK 470 LYS D 62 CE NZ REMARK 470 GLU D 74 CD OE1 OE2 REMARK 470 GLN D 75 CG CD OE1 NE2 REMARK 470 LYS D 148 CG CD CE NZ REMARK 470 ARG D 150 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 126 103.80 -58.58 REMARK 500 GLN A 138 -109.90 -127.46 REMARK 500 ASN A 145 18.74 51.57 REMARK 500 LYS A 162 -51.04 -126.06 REMARK 500 PHE B 41 -20.43 -140.51 REMARK 500 SER B 48 -167.89 -165.32 REMARK 500 GLU B 76 72.11 -65.41 REMARK 500 ARG B 245 -157.06 55.65 REMARK 500 CYS C 90 41.73 -84.92 REMARK 500 GLN C 138 -110.45 -126.48 REMARK 500 SER D 214 -57.92 -123.01 REMARK 500 ARG D 245 -153.12 51.57 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ENS B 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ENS D 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA B 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA D 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NA B 303 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NA D 303 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MES B 304 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MES D 304 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 202 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 203 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL B 305 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL D 305 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL D 306 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL D 307 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT B 306 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT D 308 REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE PROTEIN, AS ISOLATED FROM HUMAN BLOOD BY ENZYME RESEARCH REMARK 999 LABORATORIES (SOUTH BEND, IN), WAS FOUND TO BE HETEROGENEOUS BY REMARK 999 MASS SPECTROMETRY. THE REPROTED SEQRES RECORDS INCLUDE THE REMARK 999 RESIDUES CONSISTENT WITH THE CARBOXYPEPTIDASE B CLEAVAGE SITE TO REMARK 999 FORM DES-GLA PROTEIN AND THE RESIDUES MODELED IN ELECTRON REMARK 999 DENSITY. N-TERMINI OF LIGHT CHAINS (CHAINS A AND C) MODELED REMARK 999 BASED ON 1XKA. THERE MAY BE MORE RESIDUES BEYOND THESE TERMINI. DBREF 3ENS A 85 178 UNP P00742 FA10_HUMAN 85 178 DBREF 3ENS B 16 248 UNP P00742 FA10_HUMAN 235 472 DBREF 3ENS C 85 178 UNP P00742 FA10_HUMAN 85 178 DBREF 3ENS D 16 248 UNP P00742 FA10_HUMAN 235 472 SEQRES 1 A 94 LYS ASP GLY ASP GLN CYS GLU THR SER PRO CYS GLN ASN SEQRES 2 A 94 GLN GLY LYS CYS LYS ASP GLY LEU GLY GLU TYR THR CYS SEQRES 3 A 94 THR CYS LEU GLU GLY PHE GLU GLY LYS ASN CYS GLU LEU SEQRES 4 A 94 PHE THR ARG LYS LEU CYS SER LEU ASP ASN GLY ASP CYS SEQRES 5 A 94 ASP GLN PHE CYS HIS GLU GLU GLN ASN SER VAL VAL CYS SEQRES 6 A 94 SER CYS ALA ARG GLY TYR THR LEU ALA ASP ASN GLY LYS SEQRES 7 A 94 ALA CYS ILE PRO THR GLY PRO TYR PRO CYS GLY LYS GLN SEQRES 8 A 94 THR LEU GLU SEQRES 1 B 238 ILE VAL GLY GLY GLN GLU CYS LYS ASP GLY GLU CYS PRO SEQRES 2 B 238 TRP GLN ALA LEU LEU ILE ASN GLU GLU ASN GLU GLY PHE SEQRES 3 B 238 CYS GLY GLY THR ILE LEU SER GLU PHE TYR ILE LEU THR SEQRES 4 B 238 ALA ALA HIS CYS LEU TYR GLN ALA LYS ARG PHE LYS VAL SEQRES 5 B 238 ARG VAL GLY ASP ARG ASN THR GLU GLN GLU GLU GLY GLY SEQRES 6 B 238 GLU ALA VAL HIS GLU VAL GLU VAL VAL ILE LYS HIS ASN SEQRES 7 B 238 ARG PHE THR LYS GLU THR TYR ASP PHE ASP ILE ALA VAL SEQRES 8 B 238 LEU ARG LEU LYS THR PRO ILE THR PHE ARG MET ASN VAL SEQRES 9 B 238 ALA PRO ALA CYS LEU PRO GLU ARG ASP TRP ALA GLU SER SEQRES 10 B 238 THR LEU MET THR GLN LYS THR GLY ILE VAL SER GLY PHE SEQRES 11 B 238 GLY ARG THR HIS GLU LYS GLY ARG GLN SER THR ARG LEU SEQRES 12 B 238 LYS MET LEU GLU VAL PRO TYR VAL ASP ARG ASN SER CYS SEQRES 13 B 238 LYS LEU SER SER SER PHE ILE ILE THR GLN ASN MET PHE SEQRES 14 B 238 CYS ALA GLY TYR ASP THR LYS GLN GLU ASP ALA CYS GLN SEQRES 15 B 238 GLY ASP SER GLY GLY PRO HIS VAL THR ARG PHE LYS ASP SEQRES 16 B 238 THR TYR PHE VAL THR GLY ILE VAL SER TRP GLY GLU GLY SEQRES 17 B 238 CYS ALA ARG LYS GLY LYS TYR GLY ILE TYR THR LYS VAL SEQRES 18 B 238 THR ALA PHE LEU LYS TRP ILE ASP ARG SER MET LYS THR SEQRES 19 B 238 ARG GLY LEU PRO SEQRES 1 C 94 LYS ASP GLY ASP GLN CYS GLU THR SER PRO CYS GLN ASN SEQRES 2 C 94 GLN GLY LYS CYS LYS ASP GLY LEU GLY GLU TYR THR CYS SEQRES 3 C 94 THR CYS LEU GLU GLY PHE GLU GLY LYS ASN CYS GLU LEU SEQRES 4 C 94 PHE THR ARG LYS LEU CYS SER LEU ASP ASN GLY ASP CYS SEQRES 5 C 94 ASP GLN PHE CYS HIS GLU GLU GLN ASN SER VAL VAL CYS SEQRES 6 C 94 SER CYS ALA ARG GLY TYR THR LEU ALA ASP ASN GLY LYS SEQRES 7 C 94 ALA CYS ILE PRO THR GLY PRO TYR PRO CYS GLY LYS GLN SEQRES 8 C 94 THR LEU GLU SEQRES 1 D 238 ILE VAL GLY GLY GLN GLU CYS LYS ASP GLY GLU CYS PRO SEQRES 2 D 238 TRP GLN ALA LEU LEU ILE ASN GLU GLU ASN GLU GLY PHE SEQRES 3 D 238 CYS GLY GLY THR ILE LEU SER GLU PHE TYR ILE LEU THR SEQRES 4 D 238 ALA ALA HIS CYS LEU TYR GLN ALA LYS ARG PHE LYS VAL SEQRES 5 D 238 ARG VAL GLY ASP ARG ASN THR GLU GLN GLU GLU GLY GLY SEQRES 6 D 238 GLU ALA VAL HIS GLU VAL GLU VAL VAL ILE LYS HIS ASN SEQRES 7 D 238 ARG PHE THR LYS GLU THR TYR ASP PHE ASP ILE ALA VAL SEQRES 8 D 238 LEU ARG LEU LYS THR PRO ILE THR PHE ARG MET ASN VAL SEQRES 9 D 238 ALA PRO ALA CYS LEU PRO GLU ARG ASP TRP ALA GLU SER SEQRES 10 D 238 THR LEU MET THR GLN LYS THR GLY ILE VAL SER GLY PHE SEQRES 11 D 238 GLY ARG THR HIS GLU LYS GLY ARG GLN SER THR ARG LEU SEQRES 12 D 238 LYS MET LEU GLU VAL PRO TYR VAL ASP ARG ASN SER CYS SEQRES 13 D 238 LYS LEU SER SER SER PHE ILE ILE THR GLN ASN MET PHE SEQRES 14 D 238 CYS ALA GLY TYR ASP THR LYS GLN GLU ASP ALA CYS GLN SEQRES 15 D 238 GLY ASP SER GLY GLY PRO HIS VAL THR ARG PHE LYS ASP SEQRES 16 D 238 THR TYR PHE VAL THR GLY ILE VAL SER TRP GLY GLU GLY SEQRES 17 D 238 CYS ALA ARG LYS GLY LYS TYR GLY ILE TYR THR LYS VAL SEQRES 18 D 238 THR ALA PHE LEU LYS TRP ILE ASP ARG SER MET LYS THR SEQRES 19 D 238 ARG GLY LEU PRO HET GOL A 201 6 HET GOL A 202 6 HET GOL A 203 6 HET ENS B 301 36 HET CA B 302 1 HET NA B 303 1 HET MES B 304 12 HET GOL B 305 6 HET ACT B 306 4 HET ENS D 301 36 HET CA D 302 1 HET NA D 303 1 HET MES D 304 12 HET GOL D 305 6 HET GOL D 306 6 HET GOL D 307 6 HET ACT D 308 4 HETNAM GOL GLYCEROL HETNAM ENS METHYL (2Z)-3-[(3-CHLORO-1H-INDOL-7-YL)AMINO]-2-CYANO- HETNAM 2 ENS 3-{[(3S)-2-OXO-1-(2-OXO-2-PYRROLIDIN-1-YLETHYL)AZEPAN- HETNAM 3 ENS 3-YL]AMINO}ACRYLATE HETNAM CA CALCIUM ION HETNAM NA SODIUM ION HETNAM MES 2-(N-MORPHOLINO)-ETHANESULFONIC ACID HETNAM ACT ACETATE ION HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL HETSYN ENS METHYL (2Z)-3-[(3-CHLORO-1H-INDOL-7-YL)AMINO]-2-CYANO- HETSYN 2 ENS 3-{[(3S)-2-OXO-1-(2-OXO-2-PYRROLIDIN-1-YLETHYL)AZEPAN- HETSYN 3 ENS 3-YL]AMINO}PROP-2-ENOATE FORMUL 5 GOL 7(C3 H8 O3) FORMUL 8 ENS 2(C25 H29 CL N6 O4) FORMUL 9 CA 2(CA 2+) FORMUL 10 NA 2(NA 1+) FORMUL 11 MES 2(C6 H13 N O4 S) FORMUL 13 ACT 2(C2 H3 O2 1-) FORMUL 22 HOH *304(H2 O) HELIX 1 1 LEU A 131 CYS A 136 5 6 HELIX 2 2 ALA B 55 ALA B 61A 5 8 HELIX 3 3 GLU B 124A LEU B 131A 1 9 HELIX 4 4 ASP B 164 SER B 172 1 9 HELIX 5 5 PHE B 234 THR B 244 1 11 HELIX 6 6 CYS C 95 GLY C 99 5 5 HELIX 7 7 LEU C 131 CYS C 136 5 6 HELIX 8 8 ALA D 55 GLN D 61 5 7 HELIX 9 9 GLU D 124A LEU D 131A 1 9 HELIX 10 10 ASP D 164 SER D 172 1 9 HELIX 11 11 PHE D 234 THR D 244 1 11 SHEET 1 A 2 LYS A 100 CYS A 101 0 SHEET 2 A 2 CYS A 110 THR A 111 -1 O THR A 111 N LYS A 100 SHEET 1 B 2 PHE A 116 GLU A 117 0 SHEET 2 B 2 LEU A 123 PHE A 124 -1 O LEU A 123 N GLU A 117 SHEET 1 C 2 PHE A 139 GLU A 142 0 SHEET 2 C 2 VAL A 147 SER A 150 -1 O VAL A 148 N HIS A 141 SHEET 1 D 2 TYR A 155 LEU A 157 0 SHEET 2 D 2 CYS A 164 PRO A 166 -1 O ILE A 165 N THR A 156 SHEET 1 E 8 GLN B 20 GLU B 21 0 SHEET 2 E 8 LYS B 156 VAL B 163 -1 O MET B 157 N GLN B 20 SHEET 3 E 8 MET B 180 ALA B 183 -1 O CYS B 182 N VAL B 163 SHEET 4 E 8 GLY B 226 LYS B 230 -1 O TYR B 228 N PHE B 181 SHEET 5 E 8 THR B 206 GLY B 216 -1 N TRP B 215 O ILE B 227 SHEET 6 E 8 PRO B 198 PHE B 203 -1 N HIS B 199 O THR B 210 SHEET 7 E 8 THR B 135 GLY B 140 -1 N ILE B 137 O VAL B 200 SHEET 8 E 8 LYS B 156 VAL B 163 -1 O VAL B 160 N GLY B 136 SHEET 1 F 7 ALA B 81 HIS B 83 0 SHEET 2 F 7 LYS B 65 VAL B 68 -1 N VAL B 66 O HIS B 83 SHEET 3 F 7 GLN B 30 ILE B 34 -1 N LEU B 32 O ARG B 67 SHEET 4 F 7 GLY B 40 ILE B 46 -1 O CYS B 42 N LEU B 33 SHEET 5 F 7 TYR B 51 THR B 54 -1 O LEU B 53 N THR B 45 SHEET 6 F 7 ALA B 104 LEU B 108 -1 O LEU B 106 N ILE B 52 SHEET 7 F 7 VAL B 85 LYS B 90 -1 N GLU B 86 O ARG B 107 SHEET 1 G 2 LYS C 100 CYS C 101 0 SHEET 2 G 2 CYS C 110 THR C 111 -1 O THR C 111 N LYS C 100 SHEET 1 H 2 PHE C 116 GLU C 117 0 SHEET 2 H 2 LEU C 123 PHE C 124 -1 O LEU C 123 N GLU C 117 SHEET 1 I 2 PHE C 139 GLU C 142 0 SHEET 2 I 2 VAL C 147 SER C 150 -1 O VAL C 148 N HIS C 141 SHEET 1 J 2 TYR C 155 LEU C 157 0 SHEET 2 J 2 CYS C 164 PRO C 166 -1 O ILE C 165 N THR C 156 SHEET 1 K 8 GLN D 20 GLU D 21 0 SHEET 2 K 8 LYS D 156 VAL D 163 -1 O MET D 157 N GLN D 20 SHEET 3 K 8 MET D 180 ALA D 183 -1 O CYS D 182 N VAL D 163 SHEET 4 K 8 GLY D 226 LYS D 230 -1 O TYR D 228 N PHE D 181 SHEET 5 K 8 THR D 206 TRP D 215 -1 N TRP D 215 O ILE D 227 SHEET 6 K 8 PRO D 198 PHE D 203 -1 N HIS D 199 O THR D 210 SHEET 7 K 8 THR D 135 GLY D 140 -1 N ILE D 137 O VAL D 200 SHEET 8 K 8 LYS D 156 VAL D 163 -1 O VAL D 160 N GLY D 136 SHEET 1 L 7 ALA D 81 HIS D 83 0 SHEET 2 L 7 LYS D 65 VAL D 68 -1 N VAL D 66 O HIS D 83 SHEET 3 L 7 GLN D 30 ILE D 34 -1 N LEU D 32 O ARG D 67 SHEET 4 L 7 GLY D 40 ILE D 46 -1 O CYS D 42 N LEU D 33 SHEET 5 L 7 TYR D 51 THR D 54 -1 O LEU D 53 N THR D 45 SHEET 6 L 7 ALA D 104 LEU D 108 -1 O LEU D 106 N ILE D 52 SHEET 7 L 7 VAL D 85 LYS D 90 -1 N GLU D 86 O ARG D 107 SSBOND 1 CYS A 90 CYS A 101 1555 1555 2.04 SSBOND 2 CYS A 95 CYS A 110 1555 1555 2.03 SSBOND 3 CYS A 112 CYS A 121 1555 1555 2.04 SSBOND 4 CYS A 129 CYS A 140 1555 1555 2.04 SSBOND 5 CYS A 136 CYS A 149 1555 1555 2.04 SSBOND 6 CYS A 151 CYS A 164 1555 1555 2.04 SSBOND 7 CYS A 172 CYS B 122 1555 1555 2.04 SSBOND 8 CYS B 22 CYS B 27 1555 1555 2.05 SSBOND 9 CYS B 42 CYS B 58 1555 1555 2.04 SSBOND 10 CYS B 168 CYS B 182 1555 1555 2.03 SSBOND 11 CYS B 191 CYS B 220 1555 1555 2.03 SSBOND 12 CYS C 90 CYS C 101 1555 1555 2.04 SSBOND 13 CYS C 95 CYS C 110 1555 1555 2.03 SSBOND 14 CYS C 112 CYS C 121 1555 1555 2.05 SSBOND 15 CYS C 129 CYS C 140 1555 1555 2.04 SSBOND 16 CYS C 136 CYS C 149 1555 1555 2.04 SSBOND 17 CYS C 151 CYS C 164 1555 1555 2.04 SSBOND 18 CYS C 172 CYS D 122 1555 1555 2.05 SSBOND 19 CYS D 22 CYS D 27 1555 1555 2.04 SSBOND 20 CYS D 42 CYS D 58 1555 1555 2.06 SSBOND 21 CYS D 168 CYS D 182 1555 1555 2.04 SSBOND 22 CYS D 191 CYS D 220 1555 1555 2.03 SITE 1 AC1 15 GLU B 97 THR B 98 TYR B 99 GLU B 147 SITE 2 AC1 15 ASP B 189 ALA B 190 CYS B 191 GLN B 192 SITE 3 AC1 15 VAL B 213 TRP B 215 GLY B 216 GLY B 218 SITE 4 AC1 15 CYS B 220 GLY B 226 ILE B 227 SITE 1 AC2 17 ASN A 120 GLU D 97 TYR D 99 GLU D 147 SITE 2 AC2 17 ASP D 189 ALA D 190 CYS D 191 GLN D 192 SITE 3 AC2 17 VAL D 213 TRP D 215 GLY D 216 GLY D 218 SITE 4 AC2 17 CYS D 220 GLY D 226 ILE D 227 HOH D 333 SITE 5 AC2 17 HOH D 374 SITE 1 AC3 5 ASP B 70 ASN B 72 THR B 73 GLN B 75 SITE 2 AC3 5 GLU B 80 SITE 1 AC4 4 ASP D 70 ASN D 72 GLN D 75 GLU D 80 SITE 1 AC5 6 TYR B 185 ASP B 185A LYS B 186 ALA B 221 SITE 2 AC5 6 ARG B 222 LYS B 224 SITE 1 AC6 5 TYR D 185 ASP D 185A LYS D 186 ALA D 221 SITE 2 AC6 5 ARG D 222 SITE 1 AC7 6 ARG B 125 ASN B 179 ALA B 233 LYS B 236 SITE 2 AC7 6 HOH B 366 HOH B 412 SITE 1 AC8 8 PHE D 101 ARG D 125 ASN D 179 ALA D 233 SITE 2 AC8 8 LYS D 236 HOH D 349 HOH D 389 HOH D 418 SITE 1 AC9 5 PRO A 166 GLY A 168 GOL A 203 HOH A 215 SITE 2 AC9 5 HOH A 222 SITE 1 BC1 2 LEU A 157 HOH A 213 SITE 1 BC2 4 PRO A 171 LYS A 174 LEU A 177 GOL A 201 SITE 1 BC3 5 PRO B 124 LEU B 235 ASP B 239 HOH B 337 SITE 2 BC3 5 HOH B 398 SITE 1 BC4 4 LEU D 123 PRO D 124 ASP D 239 HOH D 412 SITE 1 BC5 4 ARG D 93 THR D 95 ASP D 100 HOH D 367 SITE 1 BC6 6 SER A 130 THR B 132 VAL D 87 VAL D 88 SITE 2 BC6 6 ILE D 89 HOH D 378 SITE 1 BC7 3 ASP B 185A THR B 185B LYS B 186 SITE 1 BC8 4 TYR D 185 ASP D 185A THR D 185B LYS D 186 CRYST1 62.311 78.861 73.850 90.00 102.82 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016049 0.000000 0.003652 0.00000 SCALE2 0.000000 0.012681 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013887 0.00000